The drug firm in a regulatory filing however said it is yet to receive a copy of the proceeding and denied what it said were ‘baseless allegations’ against the company.
Aurobindo Pharma says co, subsidiary made party to litigation proceeding in US
More from Industry NewsMore posts in Industry News »
- Aurobindo, Unichem recall products in US market
- After recommending booster dose for 40+, INSACOG says more experiments needed
- Omicron scare: Experts advise booster doses for health workers
- BioNTech CEO confident of quickly adapting vaccine for Omicron
- Double vaccinate against Covid first, experts say amid calls for booster shots